Bionomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 112.3%.

Top 16 shareholders own 24.39% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10%	Armistice Capital LLC	1,733,773	€462.7k	8.84%	0.01%
5.91%	Apeiron Investment Group	1,024,309	€273.4k	0.68%	0.34%
3.17%	Lynx1 Capital Management LP	549,673	€146.7k	-8.34%	0.06%
2.99%	Presight Capital	518,717	€138.4k	-34.4%	1.25%
1.82%	Point72 Asset Management, L.P.	316,000	€84.3k	0%	no data
0.2%	Susquehanna International Group, LLP, Asset Management Arm	34,138	€9.1k	0%	no data
0.19%	Spyridon Papapetropoulos	33,599	€9.0k	0%	no data
0.048%	Rhumbline Advisers Ltd Partnership	8,300	€2.2k	278%	no data
0.0087%	Peter Miles Davies	1,511	€403.1	0%	no data
0.0081%	David Wilson	1,410	€376.2	0%	no data
0.0052%	Morgan Stanley, Investment Banking and Brokerage Investments	894	€238.5	12.6%	no data
0.0041%	Elizabeth Doolin	714	€190.4	0%	no data
0.0032%	Alan Fisher	560	€149.3	0%	no data
0.0018%	Northwestern Mutual Wealth Management Company	303	€80.9	0%	no data
0.0011%	Aspire Private Capital, LLC	200	€53.2	0%	no data
0.00001%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€0.5	0%	no data